Back to top

Image: Bigstock

Hill-Rom Holdings, Inc.

Read MoreHide Full Article

Hill-Rom exited the fiscal 2018 on a strong note with fourth-quarter earnings and revenues beating the respective Zacks Consensus Estimate. Adjusted earnings increased 23% in the quarter, the 13th consecutive quarter of double-digit growth. The company saw a solid increase in revenues on robust domestic growth, driven by a sturdy performance in Patient Support Systems and Front Line Care. The company is currently focusing on product innovation. For the full year, it has achieved more than $300 million as new product revenues. In 2019, the company expects to generate more than $400 million in new product revenue, exceeding its 2020 objective one year in advance. Over the past three months, Hill-Rom outperformed tits industry. On the flip side, international revenues declined with a dip in sales in Asia-Pacific. Also, foreign exchange and a tough competitive landscape remain headwinds.

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

HillRom Holdings, Inc. (HRC) - free report >>

Published in